Breast Cancer
Researchers aimed to evaluate the roll of ERCC1 expression in predicting response to adjuvant chemotherapy for TNBC.
TILs can serve as a biomarker to identify patients with ERBB2-positive early breast cancer who can reduce adjuvant therapy.
Cancer recurrence fear appreciably impacts breast cancer survivors’ ability to re-enter the workforce.
There was a 29% increase in cancer detection with AI-supported screening.
Researchers found two effective treatments for metaplastic breast cancer.
New research has uncovered a combination therapy that shows promising results in melanoma and breast cancer models.
Aliya Omer, AstraZeneca, talks about data that backs the efficacy of olaparib in treating high-risk early breast cancer.
In patients with high-risk HER2-psoitive breast cancer, adjuvant trastuzumab emtansine reduces the long-term risk of death.
The study used SEER data of nearly 20,000 cases.
A groundbreaking study has demonstrated that artificial intelligence can enhance breast cancer detection rates by almost 20%.
Advertisement
Expert Interviews on Oncology
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
Advertisement
Section Editor
Dr. Sadie Dobrozsi, EvolentHematologist/oncologist and Medical Director, Evolent
Advertisement
Latest News
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.